Trial Profile
An open-label, randomised, cross-over study to investigate the effect of meals (low and high fat content) on the pharmacokinetics of repeated doses of Lurasidone in Schizophrenia or Schizoaffective disorder.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2014
Price :
$35
*
At a glance
- Drugs Lurasidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacokinetics
- 05 Dec 2014 New trial record